Stocktoria

Aligos Therapeutics, Inc. ALGS

Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2020-10-16 · LEI

Aligos Therapeutics, Inc. institutional holders

InvestorSharesValue% of company
D. E. Shaw & Co., Inc.66,463$383,4910.67%
RENAISSANCE TECHNOLOGIES LLC10,800$62,3160.11%

% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.